Lastacaft Description




Full Prescribing Info
Topical ophthalmic solution containing alcaftadine, 0.25% (2.5 mg/mL).
LASTACAFT is a sterile, topically administered H1 receptor antagonist containing alcaftadine for ophthalmic use. Alcaftadine is a white to yellow powder with an empirical formula of C19H21N3O and a molecular weight of 307.39.
The chemical name is 6,11‐dihydro‐11‐(1‐methyl‐4‐piperidinylidene)‐5H‐imidazo[2,1‐b] [3] benzazepine‐3‐carboxaldehyde.
The drug product has a pH of approximately 7 and an osmolality of approximately 290 mOsm/kg.
Preservative: Benzalkonium chloride 0.005% (0.05 mg/mL).
Excipients/Inactive Ingredients: Edetate disodium, monobasic sodium phosphate, purified water, sodium chloride, sodium hydroxide and/or hydrochloric acid to adjust pH.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in